National Health Investors (NHI) Depreciation & Amortization (CF) (2010 - 2026)

National Health Investors has reported Depreciation & Amortization (CF) for 17 years, with the latest figure at $23.7 million in Q1 2026.

• For the quarter ending Q1 2026, Depreciation & Amortization (CF) rose 23.67% year-over-year to $23.7 million; the trailing twelve-month figure through Mar 2026 stood at $63.8 million (down 12.68% YoY), and the FY2025 full-year result was $80.9 million, up 13.3% from the prior year.
• Depreciation & Amortization (CF) for Q1 2026 stood at $23.7 million, up from $20.2 million in the prior quarter.
• The five-year high for Depreciation & Amortization (CF) was $23.7 million in Q1 2026, with the low at $17.1 million in Q4 2023.
• Historically, Depreciation & Amortization (CF) has averaged $18.5 million across 5 years, with a median of $17.7 million in 2023.
• Annual changes were most pronounced in 2022 — Depreciation & Amortization (CF) fell 13.97% — and 2026, when it increased 23.67%.
• National Health Investors' Depreciation & Amortization (CF) stood at $17.3 million in 2022, then declined by 1.11% to $17.1 million in 2023, then advanced by 9.17% to $18.7 million in 2024, then advanced by 8.22% to $20.2 million in 2025, then increased by 17.19% to $23.7 million in 2026.
• The last three Depreciation & Amortization (CF) figures came in at $23.7 million (Q1 2026), $20.2 million (Q3 2025), and $19.9 million (Q2 2025), per Business Quant data.